Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.
about
Mechanisms of heparanase inhibitors in cancer therapy.MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73.MicroRNAs: novel players in cancer diagnosis and therapies.Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637.Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancerSerpine2, a potential novel target for combating melanoma metastasisThe prognostic significance of heparanase expression in metastatic melanomaMicroRNA regulation of proteoglycan function in cancer.HBxAg suppresses apoptosis of human placental trophoblastic cell lines via activation of the PI3K/Akt pathway.Heparanase Upregulation Contributes to Porcine Reproductive and Respiratory Syndrome Virus Release.Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.
P2860
Q30244089-ACE63743-E4DD-4F32-8B63-03AC3FE5EDE9Q33630440-85F4FC4C-7696-46F8-A6CC-15D7902F9A05Q33914573-C0C8FF8E-9377-41E2-9787-0C840D1B818CQ35584609-3905672C-DBBF-4410-9785-1610D1643DD8Q36254868-5A95FA83-AD52-4988-9E66-5EFA8106EC04Q36443049-7A185F49-CC9C-4D93-9AE4-E4F59A1454F1Q36964051-5143F3F8-3443-4467-A448-FDEF88ECB583Q37688833-659AB33B-CBE6-4880-AF9B-27E4E095CB70Q38244283-769E3DA8-3AAC-4B6B-BEA9-566B062136A3Q38782761-BDDBAC82-B3CE-4D0C-A812-95D3E1B69E55Q38793707-CBBFE9EE-52B0-45D0-BDB8-85DF9054E081Q38801721-6424DD9D-69CC-4B80-A92D-F880BE3E81F5Q38830977-61691D22-F72E-4827-893D-4E6726FDDDA5Q38902935-07F005E3-F6E4-4502-AA85-AB51F5CE08EEQ50062795-8E32D234-9ECA-4A6D-BC8C-CEBE4B4E280C
P2860
Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lentiviral miR30-based RNA int ...... lower liver and lung toxicity.
@en
Lentiviral miR30-based RNA int ...... lower liver and lung toxicity.
@nl
type
label
Lentiviral miR30-based RNA int ...... lower liver and lung toxicity.
@en
Lentiviral miR30-based RNA int ...... lower liver and lung toxicity.
@nl
prefLabel
Lentiviral miR30-based RNA int ...... lower liver and lung toxicity.
@en
Lentiviral miR30-based RNA int ...... lower liver and lung toxicity.
@nl
P2093
P2860
P356
P1476
Lentiviral miR30-based RNA int ...... lower liver and lung toxicity.
@en
P2093
Hong-chao Chen
Qiu-su Tang
Xiao-ling Jiang
Xiao-yan Liu
P2860
P304
P356
10.7150/IJBS.5425
P407
P577
2013-06-12T00:00:00Z